Baijin Life Science Holdings Ltd. is an investment company, which engages in the design, process, purchase, production, and distribution of pearl and jewellery products. The company employs 79 full-time employees The company went IPO on 2014-10-17. The firm operates the business through five segments. The Sales of Pearls and Jewellery Products segment is engaged in the design and sale of jewellery products as well as sale of pearls. The Brand marketing and Consulting Services segment is engaged in the provision of brand marketing and consulting services based on contracts with agreed terms of services. The Skincare Solutions Business segment is engaged in the sales of skincare solution products to cosmetic stores and hospitals by sales contracts as well as individuals via online sales platforms, under the brand name FO. The Research and Development Services segment is engaged in the Provision of professional scientific services. The Strategic Investment and Financial Services segment is engaged in the real estate financial assets investment.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenue
119
135
53
86
62
43
Revenue Growth (YoY)
20%
155%
-38%
39%
44%
-61%
Cost of Revenue
86
93
35
79
51
51
Gross Profit
33
41
18
7
10
-8
Selling, General & Admin
36
35
30
-3
21
34
Research & Development
--
--
--
--
--
--
Operating Expenses
33
27
27
-4
21
39
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
0
-1
-8
8
-15
-52
Income Tax Expense
-3
-1
0
0
0
0
Net Income
8
0
-7
8
-15
-51
Net Income Growth
-173%
-100%
-188%
-153%
-71%
-82%
Shares Outstanding (Diluted)
772.39
693.89
644.99
603.39
372.93
235.91
Shares Change (YoY)
14%
8%
7%
62%
57.99%
24%
EPS (Diluted)
0.01
0
-0.01
0.01
-0.04
-0.21
EPS Growth
-166%
-96%
-181%
-135%
-81%
-85%
Free Cash Flow
-20
-32
-6
-21
1
-16
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
27.73%
30.37%
33.96%
8.13%
16.12%
-18.6%
Operating Margin
0%
10.37%
-16.98%
13.95%
-16.12%
-111.62%
Profit Margin
6.72%
0%
-13.2%
9.3%
-24.19%
-118.6%
Free Cash Flow Margin
-16.8%
-23.7%
-11.32%
-24.41%
1.61%
-37.2%
EBITDA
6
20
-8
13
-9
-46
EBITDA Margin
5.04%
14.81%
-15.09%
15.11%
-14.51%
-106.97%
D&A For EBITDA
6
6
1
1
1
2
EBIT
0
14
-9
12
-10
-48
EBIT Margin
0%
10.37%
-16.98%
13.95%
-16.12%
-111.62%
Effective Tax Rate
0%
100%
0%
0%
0%
0%
Follow-Up Questions
What are Baijin Life Science Holdings Ltd's key financial statements?
According to the latest financial statement (Form-10K), Baijin Life Science Holdings Ltd has a total asset of $0, Net loss of $0
What are the key financial ratios for MNNGF?
Baijin Life Science Holdings Ltd's Current ratio is 0, has a Net margin is 0, sales per share of $0.19.
How is Baijin Life Science Holdings Ltd's revenue broken down by segment or geography?
Baijin Life Science Holdings Ltd largest revenue segment is Jewellery, at a revenue of 115,191,000 in the most earnings release.For geography, United States is the primary market for Baijin Life Science Holdings Ltd, at a revenue of 68,774,000.
Is Baijin Life Science Holdings Ltd profitable?
no, according to the latest financial statements, Baijin Life Science Holdings Ltd has a net loss of $0
Does Baijin Life Science Holdings Ltd have any liabilities?
no, Baijin Life Science Holdings Ltd has liability of 0
How many outstanding shares for Baijin Life Science Holdings Ltd?
Baijin Life Science Holdings Ltd has a total outstanding shares of 0